LFCR · Lifecore Biomedical, Inc. \De\
$4.58
-0.06 (-1.29%)
At close · Jul 22
Market Cap
$171.79M
Shares
37.51M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-02 | 2026-06-29 | |
| 8-K | 2026-06-05 | 2026-06-04 | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| 8-K | 2026-05-06 | — | |
| DEF 14A | 2026-04-24 | — | |
| 8-K | 2026-03-16 | — | |
| 8-K | 2026-03-05 | — | |
| 8-K | 2026-01-16 | 2026-01-14 | |
| 8-K | 2025-11-17 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-10-31 | 2025-10-29 | |
| 8-K | 2025-09-26 | 2025-09-22 | |
| DEF 14A | 2025-09-18 | — | |
| 8-K | 2025-08-18 | 2025-08-12 | |
| 8-K | 2025-08-12 | — | |
| 8-K | 2025-08-07 | — | |
| 10-K | 2025-08-07 | 2025-05-25 | |
| 8-K | 2025-07-18 | 2025-07-15 | |
| 8-K | 2025-04-16 | 2025-04-11 | |
| 8-K | 2025-04-10 | — | |
| 8-K | 2025-04-03 | — | |
| 10-Q | 2025-04-03 | 2025-02-23 | |
| DEF 14A | 2025-02-27 | — | |
| 8-K | 2025-01-17 | — | |
| 8-K | 2025-01-07 | — | |
| 10-Q | 2025-01-02 | 2024-11-24 | |
| 8-K | 2025-01-02 | — | |
| 8-K | 2024-11-26 | — | |
| 8-K | 2024-11-21 | — | |
| 8-K | 2024-11-08 | 2024-11-07 | |
| 10-Q | 2024-10-04 | 2024-08-25 | |
| 8-K | 2024-10-04 | 2024-10-03 | |
| 8-K | 2024-09-23 | — | |
| DEF 14A | 2024-09-23 | 2024-11-07 | |
| 8-K | 2024-09-12 | 2024-09-11 | |
| 8-K | 2024-08-29 | 2024-08-28 | |
| 10-K | 2024-08-26 | 2024-05-26 | |
| 8-K | 2024-08-26 | — | |
| 8-K | 2024-08-21 | 2024-08-15 | |
| 10-Q | 2024-08-09 | 2023-11-26 | |
| 10-Q | 2024-08-09 | 2023-08-27 | |
| 10-Q | 2024-08-09 | 2024-02-25 | |
| 8-K | 2024-07-24 | 2024-07-18 | |
| DEF 14A | 2024-07-19 | 2023-05-28 | |
| 8-K | 2024-07-12 | 2024-07-08 | |
| 8-K | 2024-07-01 | 2024-06-28 | |
| 8-K | 2024-06-07 | 2024-06-03 | |
| 8-K | 2024-05-22 | 2024-05-19 | |
| 8-K | 2024-05-16 | — |
Showing 1–50 of 143 filings
Key facts
CIK
1005286
CUSIP
514766104
13F (30d)
12 filings
12 filers
Visit website
Investor relations